CLINICAL IMMUNOLOGY
Reduced levels of T-helper 17-associated cytokines in the serum of patients with breast cancer: indicators for following the course of disease
Submission date: 2015-07-08
Final revision date: 2015-10-22
Acceptance date: 2015-10-30
Publication date: 2016-03-24
Cent Eur J Immunol 2016;41(1):78-85
KEYWORDS
ABSTRACT
Interleukin (IL)-17-producing CD4+ T helper (Th17) cells that are known to produce IL-17 have recently been defined as a unique subset of proinflammatory helper cells. Interleukin 17 is an inflammatory cytokine with robust effects on many cells. It can play important roles in the pathogenesis of diverse groups of immune-mediated diseases. In this regard, the present case-control study aimed at determining serum levels of IL-17, IL-6, and transforming growth factor β (TGF-β) in Iranian breast cancer patients. Blood samples were collected from 55 patients with breast cancer and 34 healthy individuals with no history of malignancies or autoimmune disorders, based on simple sampling. The serum levels of IL-17, IL-6 and TGF-β were measured by enzyme-linked immunosorbent assay (ELISA). The serum level of IL-6 was significantly lower in patients with breast cancer compared with healthy individuals (p = 0.0003), and also the IL-17 was lower in the patient group than in controls (p = 0.01). Interestingly, the TGF-β serum level in patients was less than in controls (p < 0.0001). As most of the cases investigated in this study were in their early stages, it can be concluded that reduced IL-17, IL-6, and TGF-β can be used as predictors for clinical stage and prognosis of cancers such as breast carcinoma.
REFERENCES (38)
1.
Mosmann TR, Cherwinski H, Bond MW, et al. (1986): Two types of murine helper T cell clone. Definition according to profiles of lymphokine activities and secreted. J Immunol 136: 2348-2357.
2.
Murphy KM, Reiner SL (2002): The lineage decisions of helper T cells. Nat Rev Immunol 2: 933-944.
3.
Harrington LE, Hatton RD, Mangan PR, et al. (2005): Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 6: 1123-1132.
4.
Xu S, Cao X (2010): Interleukin-17 and its expanding biological functions. Cell Mol Immunol 7: 164-174.
5.
Peck A, Mellins ED (2009): Breaking old paradigms: Th17 cells in autoimmune arthritis. Clin Immunol 2009; 132: 295-304.
6.
Leipe J, Grunke M, Dechant C, et al. (2010): Role of Th17 cells in human autoimmune arthritis. Arthritis Rheum 62: 2876-2885.
7.
Zambrano-Zaragoza JF, Romo-Martínez EJ, Durán-Avelar Mde J, et al. (2014): Th17 cells in autoimmune and infectious diseases. Int J Inflam 2014: 651503.
8.
Tesmer LA, Lundy SK, Sarkar S, Fox DA (2008): Th17 cells in human disease. Immunol Rev 223: 87-113.
9.
Nam JS, Terabe M, Kang MJ, et al. (2008): Transforming growth factor beta subverts the immune system into directly promoting tumor growth through interleukin-17. Cancer Res 68: 3915-3923.
10.
Shime H, Yabu M, Akazawa T, et al. (2008): Tumor-secreted lactic acid promotes IL-23/IL-17 proinflammatory pathway. J Immunol 180: 7175-7183.
11.
Lebrun JJ (2012). The dual role of TGF in human cancer: from tumor suppression to cancer metastasis. ISRN Mol Biol 2012: 1-28.
12.
Zhou Z, Sun W, Liang Y, et al. (2012): Fenofibrate inhibited the differentiation of T helper 17 cells in vitro. PPAR Res 2012: 145654.
13.
Volpe E, Servant N, Zollinger R, et al. (2008): A critical function for transforming growth factor-, interleukin 23 and proinflammatory cytokines in driving and modulating human TH-17 responses. Nat Immunol 9: 650-657.
14.
Manel N, Unutmaz D, Littman DR (2008): The differentiation of human TH-17 cells requires transforming growth factor- and induction of the nuclear receptor RORt. Nat Immunol 9: 641-649.
15.
Wilson NJ, Boniface K, Chan JR, et al. (2007): Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat Immunol 8: 950-957.
16.
Acosta-Rodriguez EV, Napolitani G, Lanzavecchia A, Sallusto F (2007): Interleukins 1 and 6 but not transforming growth factor- are essential for the differentiation of interleukin 17-producing human T helper cells. Nat Immunol 8: 942-949.
17.
Passos ST, Silver JS, O’Hara AC (2010): IL-6 promotes NK cell production of IL-17 during toxoplasmosis. J Immunol 2010; 184: 1776-1783.
18.
Mucida D, Cheroutre H (2007): TGFbeta and retinoic acid intersect in immune-regulation. Cell Adh Migr 1: 142-144.
19.
Mucida D, Park Y, Kim G, et al. (2007): Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science 317: 256-260.
20.
Wang L, Yi T, Kortylewski M, et al. (2009): IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway. J Exp Med 206: 1457-1464.
21.
Kato T, Furumoto H, Ogura T, et al. (2001): Expression of IL-17 mRNA in ovarian cancer. Biochem Biophys Res Commun 282: 735-738.
22.
Radosavljevic G, Ljujic B, Jovanovic I, et al. (2010): Interleukin-17 may be a valuable serum tumor marker in patients with colorectal carcinoma. Neoplasma 57: 135-144.
23.
Muranski P, Boni A, Antony PA, et al. (2008): Tumor-specific Th17-polarized cells eradicate large established melanoma. Blood 112: 362-373.
24.
Jovanovic DV, Di Battista JA, Martel-Pelletier J, et al. (1998): IL-17 stimulates the production and expression of proinflammatory cytokines, IL-beta and TNF-alpha, by human macrophages. J Immunol 160: 3513-3521.
25.
Antonysamy MA, Fanslow WC, Fu F, et al. (1999): Evidence for a role of IL-17 in organ allograft rejection: IL-17 promotes the functional differentiation of dendritic cell progenitors. J Immunol 162: 577-584.
26.
Mousavi SM, Montazeri A, Mohagheghi MA, et al. (2007): Breast cancer in Iran: an epidemiological review. Breast J 13: 383-391.
27.
Liu ZJ, Yadav PK, Su JL, et al. (2009): Potential role of Th17 cells in the pathogenesis of inflammatory bowel disease. World J Gastroenterol 15: 5784-5788.
28.
Park H, Li Z, Yang XO, et al. (2005): A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 6: 1133-1141.
29.
Baharlou R, Ahmadi Vasmehjani A, Dehghani A, et al. (2014): Reduced interleukin-17 and transforming growth factor beta levels in peripheral blood as indicators for following the course of bladder cancer. Immune Netw 14: 156-163.
30.
Zhang JP, Yan J, Xu J, et al. (2009): Increased intratumoral IL-17-producing cells correlate with poor survival in hepatocellular carcinoma patients. J Hepatol 50: 980-989.
31.
Numasaki M, Fukushi J, Ono M, et al. (2003): Interleukin-17 promotes angiogenesis and tumor growth. Blood 101: 2620-2627.
32.
Wang L, Yi T, Zhang W, et al. (2010): IL-17 enhances tumor development in carcinogen-induced skin cancer. Cancer Res 70: 10112-10120.
33.
Radosavljevic G, Ljujic B, Jovanovic I, et al. (2009): Interleukin-17 may be a valuable serum tumor marker in patients with colorectal carcinoma. Neoplasma 57: 135-144.
34.
Kwon KA, Kim SH, Oh SY, et al. (2010): Clinical significance of preoperative serum vascular endothelial growth factor, interleukin-6, and C-reactive protein level in colorectal cancer. BMC Cancer 10: 203.
35.
Ravishankaran P, Karunanithi R (2011): Clinical significance of preoperative serum interleukin-6 and C-reactive protein level in breast cancer patients. World J Surg Oncol 9: 18.
36.
Weaver CT, Hatton RD (2009): Interplay between the TH17 and TReg cell lineages: a (co-) evolutionary perspective. Nat Rev Immunol 9: 883-889.
37.
Hsu HC, Yang P, Wang J, et al. (2008): Interleukin 17-producing T helper cells and interleukin 17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice. Nat Immunol 9: 166-175.
38.
Connolly EC, Freimuth J, Akhurst RJ. Complexities of TGF-beta targeted cancer therapy. Int J Biol Sci 2012; 8: 964-978.
| eISSN: | 1644-4124 |
| ISSN: | 1426-3912 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
